Remicade Biosimilar FDA Panel Vote Shows How It Can Be Done
February 10, 2016
John T. Aquino
Life Sciences Law & Industry Report
Axinn counsel Stacie Ropka was quoted in the Life Sciences Law & Industry Report, "Remicade Biosimilar FDA Panel Vote Shows How It Can Be Done."